Related Experiment Video

Updated: Aug 10, 2026

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration
10:43

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration

Published on: May 19, 2016

A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase

Cynthia S Collins1, Jiyong Hong, Lisa Sapinoso

  • 1Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, CA 92121, USA.

Proceedings of the National Academy of Sciences of the United States of America
|March 16, 2006
PubMed

Insights

Researchers screened 10,996 small interfering RNAs to find inhibitors of cell migration. They identified four genes, including MAP4K4, that potently block ovarian cancer cell movement and invasion, suggesting new therapeutic targets.

Area of Science:

  • Cellular biology
  • Molecular oncology
  • Genomics

Background:

  • Cell motility is crucial for biological processes, including cancer metastasis.
  • Identifying regulators of cell migration is key for understanding and treating cancer progression.

Purpose of the Study:

  • To conduct a genome-wide screen to identify novel inhibitors of cancer cell migration.
  • To investigate the role of identified genes, particularly MAP4K4, in cell motility and invasion.

Main Methods:

  • A library of 10,996 small interfering RNAs targeting 5,234 human genes was screened.
  • A 384-well wound-healing assay with automated microscopy was used to quantify cell migration.
  • Knockdown and small molecule inhibition studies were performed to validate findings.

Main Results:

  • Four genes (CDK7, DYRK1B, MAP4K4, SCCA-1) were identified as potent inhibitors of SKOV-3 cell migration.
  • MAP4K4 knockdown inhibited migration and invasion in multiple carcinoma cell lines.
  • MAP4K4's effect on migration is mediated via c-Jun N-terminal kinase (JNK) signaling.

Conclusions:

  • MAP4K4 plays a significant role in promoting carcinoma cell migration and invasion.
  • Inhibition of the MAP4K4-JNK pathway presents a potential therapeutic strategy for blocking cancer metastasis.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection11:00

Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection

Published on: June 23, 2023

Related Concept Videos

Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: